Materialise Reports First Quarter 2022 Results

Rhea-AI Summary

Materialise NV (NASDAQ:MTLS) reported a first-quarter revenue increase of 16.3% to 52,961 kEUR compared to 45,554 kEUR in Q1 2021. Adjusted EBITDA rose to 5,443 kEUR, slightly up from 5,341 kEUR year-over-year. The company achieved a net profit of 127 kEUR, improving from a loss of (3,642) kEUR in Q1 2021. Key segments saw growth, particularly Materialise Manufacturing, which increased revenue by 26.2%. Cash flow from operating activities rose to 11,111 kEUR, indicating operational improvement amid ongoing global challenges.

Positive

• Total revenue increased 16.3% to 52,961 kEUR in Q1 2022.
• Net profit reached 127 kEUR, a significant improvement from a loss of 3,642 kEUR in Q1 2021.
• Materialise Manufacturing segment saw a revenue increase of 26.2%.

Negative

• Adjusted EBITDA margin decreased to 10.3% from 11.7% year-over-year.
• Segment EBITDA for Materialise Software dropped significantly due to investments in Link3D.

LEUVEN, Belgium--(BUSINESS WIRE)-- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2022.

Highlights – First Quarter 2022

• Total revenue increased 16.3% to 52,961 kEUR compared to 45,554 kEUR for the first quarter of 2021.
• Total deferred revenues from annual software sales and maintenance fees increased by 2,937 kEUR this quarter to 38,082 kEUR.
• Adjusted EBITDA increased to 5,443 kEUR for the first quarter of 2022 from 5,341 kEUR for the 2021 period.
• Net profit for the first quarter of 2022 was 127 kEUR, or 0.0 EUR per diluted share, compared to (3,642) kEUR, or (0.07) EUR per diluted share, for the 2021 period.

Executive Chairman Peter Leys commented, “While the global economy was negatively impacted by a combination of geopolitical instability and the COVID-19 pandemic, Materialise continued to perform well. After posting record numbers for 2021, all of our segments grew during the first quarter of 2022, with an aggregate revenue increase of 16% on a consolidated basis, driven by the continued recovery of Materialise Manufacturing. We are particularly pleased that our deferred revenue from annual software sales and maintenance fees increased significantly, underscoring the solid recurring sales performance of our Materialise Software and Materialise Medical segments. Moreover, our Adjusted EBITDA for the quarter was 5,443 kEUR, slightly above last year’s, and included the continued operational investments in Link3D, a developer of AM manufacturing execution systems that we acquired on January 4, 2022.”

First Quarter 2022 Results

Total revenue for the first quarter of 2022 increased 16.3% to 52,961 kEUR from 45,554 kEUR for the first quarter of 2021. Adjusted EBITDA increased to 5,443 kEUR for the first quarter of 2022 from 5,341 kEUR for the 2021 period. The Adjusted EBITDA margin (Adjusted EBITDA divided by total revenue) for the first quarter of 2022 was 10.3%, compared to 11.7% for the first quarter of 2021.

The results of Link3D have been fully consolidated with the results of our Materialise Software segment as of the beginning of this year. Revenue from Materialise Software increased 2.6% to 10,483 kEUR for the first quarter of 2022 from 10,219 kEUR for the same quarter last year. Segment EBITDA decreased, including the effect of ongoing investments in Link3D, to 1,932 kEUR from 3,429 kEUR while the segment EBITDA margin was 18.4% compared to 33.6% for the prior-year period.

Revenue from our Materialise Medical segment increased 13.0% to 18,347 kEUR for the first quarter of 2022 compared to 16,231 kEUR for the same period in 2021. Segment EBITDA amounted to 3,227 kEUR for the first quarter of 2022 compared to 4,541 kEUR while the segment EBITDA margin was 17.6% compared to 28.0% for the first quarter of 2021.

Revenue from our Materialise Manufacturing segment increased 26.2% to 24,131 kEUR for the first quarter of 2022 from 19,114 kEUR for the first quarter of 2021. Segment EBITDA increased to 2,613 kEUR from (144) kEUR while the segment EBITDA margin grew to 10.8% compared to (0.8)% for the first quarter of 2021.

Gross profit grew to 28,884 kEUR compared to 24,568 kEUR for the same period last year, while gross profit as a percentage of revenue increased to 54.5% compared to 53.9% for the first quarter of 2021.

Research and development (“R&D”), sales and marketing (“S&M”) and general and administrative (“G&A”) expenses increased, in the aggregate, 17.2% to 29,773 kEUR for the first quarter of 2022 from 25,398 kEUR for the first quarter of 2021.

Net other operating income was 938 kEUR compared to 1,120 kEUR for the first quarter of 2021.

Operating result amounted to 49 kEUR compared to 290 kEUR for the first quarter of 2021.

Net financial result was 376 kEUR compared to (4,112) kEUR for the first quarter of 2021.

The first quarter of 2022 contained income tax expenses of (298) kEUR, compared to 181 kEUR income tax income in the first quarter of 2021.

As a result of the above, net profit for the first quarter of 2022 was 127 kEUR, compared to (3,642) kEUR for the same period in 2021. Total comprehensive income for the first quarter of 2022, which includes exchange differences on translation of foreign operations, was 1,543 kEUR compared to (3,150) kEUR for the 2021 period.

At March 31, 2022, we had cash and cash equivalents of 169,610 kEUR compared to 196,028 kEUR at December 31, 2021. Gross debt amounted to 93,583 kEUR, compared to 99,107 kEUR at December 31, 2021. As a result, our net cash position (gross debt less cash and cash equivalents) was 76,027 kEUR, a decrease of 20,894 kEUR, and included the effect of our call option exercise to acquire 100% of the shares of Link3D.

Cash flow from operating activities for the first quarter of 2022 increased to 11,111 kEUR from 4,231 kEUR for the same period in 2021. Total capital expenditures for the first quarter of 2022 amounted to 3,499 kEUR.

Net shareholders’ equity at March 31, 2022 was 234,121 kEUR compared to 232,577 kEUR at December 31, 2021.

Non-IFRS Measures

Materialise uses EBITDA and Adjusted EBITDA as supplemental financial measures of its financial performance. EBITDA is calculated as net profit plus income taxes, financial expenses (less financial income), shares of profit or loss in a joint venture and depreciation and amortization. Adjusted EBITDA is determined by adding share-based compensation expenses, acquisition-related expenses of business combinations, impairments and revaluation of fair value due to business combinations to EBITDA. Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect the impact of long-term investment and financing decisions, rather than the performance of the company’s day-to-day operations. As compared to net profit, these measures are limited in that they do not reflect the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in the company’s business, or the charges associated with impairments. Management evaluates such items through other financial measures such as capital expenditures and cash flow provided by operating activities. The company believes that these measurements are useful to measure a company’s ability to grow or as a valuation measurement. The company’s calculation of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. EBITDA and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in accordance with IFRS. The company’s presentation of EBITDA and Adjusted EBITDA should not be construed to imply that its future results will be unaffected by unusual or non-recurring items.

Exchange Rate

This document contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this document were made at a rate of EUR 1.00 to USD 1.1101, the reference rate of the European Central Bank on March 31, 2022.

Conference Call and Webcast

Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the first quarter of 2022 on Thursday, April 28, 2022, at 8:30 a.m. ET/2:30 p.m. CET. Company participants on the call will include Wilfried Vancraen, Founder and Chief Executive Officer; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A question-and-answer session will follow management’s remarks.

• To access the conference call, please dial 844-469-2530 (U.S.) or 765-507-2679 (international), passcode 2437458#.

The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at http://investors.materialise.com. A webcast of the conference call will be archived on the company's website for one year.

About Materialise

Materialise incorporates 30 years of 3D printing experience into a range of software solutions and 3D printing services, which form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the current armed conflict in Ukraine and the COVID-19 pandemic and related public health measures, as well as the related actions we are taking in response), and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's most recent actual results to differ materially from our expectations, including risk factors described in the company's most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this press release.

The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.

Consolidated income statements (Unaudited)
		for the three months ended March 31,
In '000		2022			2022			2021*
		U.S.$			€			€
Revenue		58,792			52,961			45,554
Cost of Sales		(26,729	)		(24,078	)		(20,986	)
Gross Profit		32,064			28,884			24,568
Gross profit as % of revenue		54.5	%		54.5	%		53.9	%
Research and development expenses		(8,675	)		(7,814	)		(6,536	)
Sales and marketing expenses		(15,003	)		(13,515	)		(11,310	)
General and administrative expenses		(9,373	)		(8,444	)		(7,552	)
Net other operating income (expenses)		1,041			938			1,120
Operating (loss) profit		54			49			290
Financial expenses		(1,431	)		(1,289	)		(4,701	)
Financial income		1,849			1,665			589
Share in loss of joint venture		-			-			-
(Loss) profit before taxes		472			425			(3,822	)
Income Taxes (*)		(331	)		(298	)		181
Net (loss) profit for the period (*)		141			127			(3,642	)
Net (loss) profit attributable to:		-
The owners of the parent		148			134			(3,642	)
Non-controlling interest		(7	)		(7	)		-
Earning per share attributable to owners of the parent
Basic		0.00			0.00			(0.07	)
Diluted		0.00			0.00			(0.07	)
Weighted average basic shares outstanding		59,064			59,064			54,169
Weighted average diluted shares outstanding		59,102			59,102			54,169

(*)	The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
	Impact on Net profit for the period and on Income taxes is 26 k€.

Consolidated statements of comprehensive income (Unaudited)
		for the three months ended March 31,
In 000€		2022			2022			2021(*)
		U.S.$			€			€
Net profit (loss) for the period (*)		141			127			(3,642	)
Other comprehensive income
Recycling
Exchange difference on translation of foreign operations		1,572			1,416			492
Non-recycling
Fair value adjustments through OCI - Equity instruments		-			-			-
Other comprehensive income (loss), net of taxes		1,572			1,416			492
Total comprehensive income (loss) for the year, net of taxes		1,713			1,543			(3,150	)
Total comprehensive income (loss) attributable to:
The owners of the parent		1,720			1,549			(3,150	)
Non-controlling interests		(7	)		(7	)		-

(*)	The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
	Impact on Net profit for the period is 26k€.

Consolidated statement of financial position (Unaudited)
		As of March 31,		As of December 31,
In 000€		2022		2021
Assets
Non-current assets
Goodwill		43,548		18,726
Intangible assets		38,075		31,668
Property, plant & equipment		84,329		84,451
Right-of-Use assets		9,270		9,054
Investments in joint ventures		-		-
Deferred tax assets		393		227
Investments in convertible loans		3,622		3,560
Investments in non-listed equity instruments		399		399
Other non-current assets		5,404		7,520
Total non-current assets		185,040		155,605
Current assets
Inventories		12,720		11,295
Trade receivables		38,575		41,541
Other current assets		8,169		8,940
Cash and cash equivalents		169,610		196,028
Total current assets		229,074		257,803
Total assets		414,115		413,408

		As of March 31,			As of December 31,
In 000€		2022			2021
Equity and liabilities
Equity
Share capital		4,489			4,489
Share premium		233,872			233,872
Retained earnings and other reserves		(4,240	)		(5,784	)
Equity attributable to the owners of the parent		234,121			232,577
Non-controlling interest		(6	)		1
Total equity		234,115			232,578
Non-current liabilities
Loans & borrowings		66,759			72,637
Lease liabilities		5,670			5,268
Deferred tax liabilities		4,295			4,371
Deferred income		5,555			4,952
Other non-current liabilities		2,681			2,168
Total non-current liabilities		84,960			89,396
Current liabilities
Loans & borrowings		17,882			17,849
Lease liabilities		3,272			3,353
Trade payables		20,202			20,171
Tax payables		722			783
Deferred income		37,226			33,306
Other current liabilities		15,736			15,972
Total current liabilities		95,040			91,434
Total equity and liabilities		414,115			413,408

Consolidated statement of cash flows (Unaudited)
		for the three months ended March 31,
In 000€		2022			2021*
Operating activities
Net (loss) profit for the period (*)		127			(3,642	)
Non-cash and operational adjustments
Depreciation of property plant & equipment		3,840			3,803
Amortization of intangible assets		1,602			1,277
Impairment of goodwill and intangible assets		-			-
Share-based payment expense		(48	)		(415	)
Loss (gain) on disposal of property, plant & equipment		(18	)		(32	)
Movement in provisions		2			-
Movement reserve for bad debt and slow moving inventory		130			(2	)
Financial income		(1,618	)		(589	)
Financial expense		1,237			4,701
Impact of foreign currencies		(28	)		18
Share in loss (gain) of a joint venture (equity method)		-			-
(Deferred) income taxes (*)		302			(181	)
Other non-current liabilities		-			-
Working capital adjustments		5,923			(860	)
Decrease (increase) in trade receivables and other receivables		4,506			(931	)
Decrease (increase) in inventories and contracts in progress		(1,357	)		(329	)
Increase (decrease) in trade payables and other payables		2,774			400
Income tax paid & Interest received		(341	)		153
Net cash flow from operating activities		11,111			4,231

(*)	The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
	Impact on Net profit for the period and on (Deferred) income taxes is 26 k€.

		for the three months ended March 31,
In 000€		2022			2021
Investing activities
Purchase of property, plant & equipment		(2,376	)		(1,242	)
Purchase of intangible assets		(1,123	)		(768	)
Proceeds from the sale of property, plant & equipment & intangible assets (net)		93			183
Acquisition of subsidiary (net of cash)		(27,414	)		-
(Convertible) Loans granted		-			(1,122	)
Other equity investments in non-listed entities		-			-
Net cash flow used in investing activities		(30,820	)		(2,949	)
Financing activities
Repayment of loans & borrowings		(5,969	)		(3,918	)
Repayment of leases		(881	)		(1,066	)
Capital increase		-			-
Interest paid		(515	)		(536	)
Other financial income (expense)		(89	)		136
Net cash flow from (used in) financing activities		(7,452	)		(5,384	)
Net increase/(decrease) of cash & cash equivalents		(27,161	)		(4,102	)
Cash & Cash equivalents at the beginning of the year		196,028			111,538
Exchange rate differences on cash & cash equivalents		743			132
Cash & cash equivalents at end of the period		169,610			107,568

Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)
		for the three months ended March 31,
In 000€		2022			2021 (*)
Net profit (loss) for the period (*)		127			(3,642	)
Income taxes (*)		298			(181	)
Financial expenses		1,289			4,701
Financial income		(1,665	)		(589	)
Depreciation and amortization		5,442			5,081
Share in loss of joint venture		-			-
EBITDA		5,491			5,371
Share-based compensation expense (1)		(48	)		(415	)
Acquisition-related expenses of business combinations (2)		-			385
Adjusted EBITDA		5,443			5,341

(1)	Share-based compensation expense represents the cost of equity-settled and share-based payments to employees.
(2)	Acquisition-related expenses of business combinations represents expenses incurred in connection with the acquisition of our option to buy Link3D
(*)	The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
	Impact on Net profit for the period and Income taxes is 26 k€.

Segment P&L (Unaudited)
In 000€		Materialise Software			Materialise Medical			Materialise Manufacturing			Total segments			Unallocated (1)			Consolidated
For the three months ended March 31, 2022
Revenues		10,483			18,347			24,131			52,961			0			52,961
Segment (adj) EBITDA		1,932			3,227			2,613			7,772			(2,329	)		5,443
Segment (adj) EBITDA %		18.4	%		17.6	%		10.8	%		14.7	%					10.3	%
For the three months ended March 31, 2021
Revenues		10,219			16,231			19,114			45,564			(11	)		45,553
Segment (adj) EBITDA		3,429			4,541			(144	)		7,826			(2,486	)		5,341
Segment (adj) EBITDA %		33.6	%		28.0	%		-0.8	%		17.2	%					11.7	%

(1) Unallocated segment adjusted EBITDA consists of corporate research and development, corporate headquarter costs and corporate other operating income (expense), and the added share-based compensation expenses, acquisition related expenses of business combinations, impairments and fair value of business combinations that are included in Adjusted EBITDA.

Reconciliation of Net Profit (Loss) to Segment adjusted EBITDA (Unaudited)
		for the three months ended March 31,
In 000€		2022			2021 (*)
Net profit (loss) for the period (*)		127			(3,642	)
Income taxes (*)		298			(181	)
Financial cost		1,289			4,701
Financial income		(1,665	)		(589	)
Share in loss of joint venture		-			-
Operating (loss) profit		49			289
Depreciation and amortization		5,442			5,081
Corporate research and development		816			692
Corporate headquarter costs		2,106			2,648
Other operating income (expense)		(640	)		(855	)
Segment adjusted EBITDA		7,772			7,855

(*)	The year 2021 has been restated to reflect the final accounting of the business combination with RS Print.
	Impact on Net profit for the period and Income taxes is 26 k€.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220428005079/en/

Investor Relations

Harriet Fried

LHA

212.838.3777

hfried@lhai.com

Source: Materialise NV

FAQ

What were the total revenues for Materialise NV in Q1 2022?

Materialise NV reported total revenues of 52,961 kEUR for the first quarter of 2022.

How did the net profit of Materialise NV change in Q1 2022 compared to Q1 2021?

The net profit for Q1 2022 was 127 kEUR, compared to a loss of 3,642 kEUR in Q1 2021.

What was the revenue growth percentage for Materialise Manufacturing in Q1 2022?

Materialise Manufacturing reported a revenue growth of 26.2% in Q1 2022.

How did the adjusted EBITDA margin for Materialise NV change in Q1 2022?

The adjusted EBITDA margin decreased to 10.3% in Q1 2022, down from 11.7% in Q1 2021.

What was the cash flow from operating activities for Materialise NV in Q1 2022?

Cash flow from operating activities increased to 11,111 kEUR in Q1 2022.